Macquarie Initiates Coverage On Surgery Partners with Outperform Rating, Announces Price Target of $31
Portfolio Pulse from Benzinga Newsdesk
Macquarie has initiated coverage on Surgery Partners (NASDAQ:SGRY) with an Outperform rating and a price target of $31.

June 28, 2024 | 10:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Macquarie has initiated coverage on Surgery Partners with an Outperform rating and a price target of $31, indicating a positive outlook for the stock.
The initiation of coverage with an Outperform rating and a specific price target of $31 by Macquarie suggests a positive sentiment from the analyst. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100